Protalix Biotherapeutics Stock Story

PLX Stock  USD 1.27  0.02  1.60%   
Slightly above 51% of Protalix Biotherapeutics' investor base is interested to short. The analysis of the overall investor sentiment regarding Protalix Biotherapeutics suggests that many traders are impartial. Protalix Biotherapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Protalix Biotherapeutics. The current market sentiment, together with Protalix Biotherapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Protalix Biotherapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Protalix Biotherapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Protalix daily returns and investor perception about the current price of Protalix Biotherapeutics as well as its diversification or hedging effects on your existing portfolios.
  

Requested story not found. it has been either deleted or moved. View all stories for Protalix Biotherapeutics.

Protalix Biotherapeutics Latest Timeline

Protalix Biotherapeutics is traded for 1.27. The company reported the last year's revenue of 65.49 M. Total Income to common stockholders was 8.31 M with profit before taxes, overhead, and interest of 28.05 M.
When determining whether Protalix Biotherapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Protalix Biotherapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Protalix Biotherapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Protalix Biotherapeutics Stock:
Check out Protalix Biotherapeutics Hype Analysis, Protalix Biotherapeutics Correlation and Protalix Biotherapeutics Performance.
For more information on how to buy Protalix Stock please use our How to Invest in Protalix Biotherapeutics guide.
You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Complementary Tools for Protalix Stock analysis

When running Protalix Biotherapeutics' price analysis, check to measure Protalix Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protalix Biotherapeutics is operating at the current time. Most of Protalix Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Protalix Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protalix Biotherapeutics' price. Additionally, you may evaluate how the addition of Protalix Biotherapeutics to your portfolios can decrease your overall portfolio volatility.
Money Managers
Screen money managers from public funds and ETFs managed around the world
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Is Protalix Biotherapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protalix Biotherapeutics. If investors know Protalix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protalix Biotherapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.39)
Earnings Share
0.09
Revenue Per Share
0.97
Quarterly Revenue Growth
0.217
Return On Assets
0.0933
The market value of Protalix Biotherapeutics is measured differently than its book value, which is the value of Protalix that is recorded on the company's balance sheet. Investors also form their own opinion of Protalix Biotherapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protalix Biotherapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protalix Biotherapeutics' market value can be influenced by many factors that don't directly affect Protalix Biotherapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protalix Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protalix Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protalix Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.